PDF
(Download)
|
- Cocoa (Theobroma cacao)
- Endothelial Function
- Hyperglycemia
- Atherosclerosis
| Date:
10-15-2012 | HC# 091221-458
|
Re: Cocoa Flavanols May Contribute to Vascular Health
Grassi D, Desideri G,
Necozione S, et al. Protective effects of flavanol-rich dark chocolate on
endothelial function and wave reflection during acute hyperglycemia. Hypertension. September 2012;60(3):827-832.
Cocoa (Theobroma cacao) and chocolate have been shown to improve endothelial function in healthy,
hypertensive, and glucose-intolerant individuals; however, the effects have
never been tested in hyperglycemic individuals. Hyperglycemia can cause
endothelial dysfunction and impair nitric oxide (NO) production, both of which
can lead to atherosclerosis. This randomized, single-blind, controlled,
crossover study focused on the effects of a flavanol-rich dark chocolate (DC)
on flow-mediated dilation (FMD), wave reflections, blood pressure (BP),
endothelin-1 (ET-1), and oxidative stress, before and after an oral glucose
tolerance test (OGTT), in healthy subjects.
Subjects included 12
healthy individuals (5 males and 7 females; mean age=28.2 ± 2.7 years)
recruited from the staff at the San Salvatore Regional Hospital and University
of L'Aquila, Italy. Smokers, those on prescription medications, and intensive
athletes were excluded. After a 7-day cocoa-free run-in period, subjects were
given 100 g DC bars (Cioccolato Bonajuto; Antica Dolceria Bonajuto; Sicily,
Italy) or isocaloric 100 g white chocolate (WC; control) bars (Milka®;
Kraft Foods; East Hanover, New Jersey) to consume in the morning for 3 days. After
a 7-day washout period, subjects were crossed over to the other treatment. The DC
contained 447 mg of epicatechin, 59 mg of catechin, and 14 mg of quercetin,
whereas the WC only contained trace amounts of polyphenols. Subjects were
instructed to refrain from eating other flavanol-rich foods and to maintain
their usual level of exercise. Instructions were given on how to modify diets
so that the chocolate calories did not add to usual caloric intake. The
subjects were also told not to disclose to the researchers which treatment they
were on in order to maintain blinding.
Before and after the OGTT,
the following measures were taken: FMD; office systolic BP (SBP) and diastolic BP
(DBP); pulse contour analysis for measuring stiffness index (SI), reflection
index (RI), and peak-to-peak time (PPT); and serum ET-1 and 8-iso-prostaglandin
F2α (8-iso-PGF2α).
Baseline clinical
characteristics were all within the average range. DC consumption statistically
significantly improved FMD compared to WC consumption (8.51 ± 0.69% vs. 7.88 ± 0.68%;
P=0.03). After WC consumption, FMD fell statistically significantly in both
groups at 60, 120, and 180 minutes post-glucose load, but not in the DC group;
DC consumption prevented FMD attenuation (P=0.0007).
DC ingestion
decreased baseline SI (P<0.05) and RI values (59.3 ± 12.4% vs. 50.4 ± 8%;
P=0.04), and increased PPT (265.5 ± 35.1 ms vs. 295.6 ± 36.2 ms; P=0.05); whereas
SI and RI values increased and PPT decreased with WC treatment.
Baseline SBP and DBP
were not different between the groups. DBP statistically significantly
increased after 30, 60, and 90 minutes following WC treatment; DC treatment attenuated
this increase induced by the glucose load for both SBP (P<0.0001) and DBP (P<0.019).
ET-1 statistically
significantly increased after WC treatment at 30, 60, 90,120, and 180 minutes
following glucose load. DC treatment prevented this increase (P=0.0023). A
similar pattern was seen for isoprostane (8-iso-PGF2α) with WC consumption
at 30 and 60 minutes post-glucose load, which DC consumption attenuated
(P=0.0008).
No significant
differences were observed regarding glucose and insulin responses during the
OGTT, homeostasis model assessment of insulin resistance, quantitative insulin
sensitivity check index, or homeostatic model assessment of β-cell function.
This study showed
that short-term treatment of healthy subjects with DC can increase
endothelium-dependent vasodilation and reduce wave reflections, lipid
peroxidation, and ET-1 levels, and protect from acute vascular alterations
induced by a glucose load. The authors did not examine mechanisms of action in
this study, but note that effects on NO and oxidative stress have been documented.
Limitations of the study include its small size, limited duration, and
incomplete blinding. In addition, the isocaloric nature of the control did not
necessarily reflect real chocolate consumption patterns, though chocolate
itself does abide by the recommended proportions of nutrients. Further studies
should test the ability of lower doses to cause similar effects.
—Risa Schulman,
PhD
|